Market
Graphy newly holds 4,087,749 common shares of Ray Purchased shares from Ray Holdings and others on the 15th and 16th for 12,024 won per share
Graphy has secured a 26.14% stake in KOSDAQ-listed Ray.
In a report on holdings of specific securities by executives and major shareholders submitted to the Data Analysis, Retrieval and Transfer System (DART) on the 22nd, Graphy disclosed that it held 4,087,749 common shares of Ray. This represents 26.14% of Ray’s total 15,640,021 issued shares.
This was a new filing; Graphy held no shares in its previous report. Graphy acquired the Ray shares through off-market purchases over two days, the 15th and 16th.
On the 15th, it purchased 2,401,521 common shares from Ray Holdings and Lee Sang-cheol, and on the 16th, it purchased 1,686,228 shares from Ray Holdings. The purchase price was 12,024 won per share.
Graphy is a domestic corporation headquartered at Gasan digital 1-ro in Geumcheon-gu, Seoul. Its relationship with Ray was listed as that of a de facto controlling shareholder.
Biobook Team
biobookmedia@biobook.co.kr
ViOL Medical Wins Thai Approval for HIFU Device, Laying Groundwork for Consumables Revenue
SCD Pharm’s glaucoma drug Latast reaches 11% market share, supplied back to originator
Alteogen’s ALT-B4 Infringes Halozyme Patent in Europe; Keytruda SC Sales Banned in 8 Countries
Immunology Drug Developer TrexBio Prices $117 Million IPO
CKD’s third-generation Lee Ju-won becomes second-largest shareholder as new drug R&D faces a test
HLB Makes Fourth Bid for Liver Cancer Drug Approval; Uncertainty Remains Despite Less Severe Inspection Outcome
Peptone nears end of two-year Lilly technology evaluation…follow-on deal could be pivotal
HLB Pharmaceutical Completes 60.8 Billion Won Rights Offering, Bets on New Hyangnam Plant as Management Participation Grows
Song Young-sook sells 86 billion won stake; buyer is daughter’s one-person company — Is a second round of Hanmi control battle looming?
